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Autologous platelet concentrates represent promising innovative tools in the field of regenerative
medicine and are successfully used in oral surgery. Several commercial systems exist that
generate various forms of platelet concentrates including Platelet-rich plasma (PRP) and Plateletrich fibrin (PRF). The alpha- granules of entrapped platelets release a variety of peptide growth
factors that promotes healing. Usually PRP is a suspension that can be injected into the site of
injury or used as a gel with the addition of thrombin (PRP-gel). In contrast Choukroun’s L-PRF
is a dense fibrin based biomaterial enriched with platelets and growth factors. The physical state
of these natural biomaterials especially L-PRF permits manual handling and suturing onto the
tissue bead to improve healing. However, our knowledge about the mechanical characteristic of
L-PRF is quite limited and a good understanding of material properties will enable expansion of

current clinical applications. This study demonstrates the techniques to identify L-PRF’s
mechanical properties (uniaxial tensile testing and suture retention strength); morphology
(scanning electron microscope); biological stability and cytocompatibility.
Objectives: This paper is intended to provide insights into basic attributes of L-PRF including its
mechanical properties (uniaxial tensile testing and suture retention strength); morphology by
scanning electron microscopy; biological stability and cytocompatibility.

Results: The mechanical properties were evaluated in two modes: uniaxial tensile testing and
suture retention strength test. The results demonstrate viscoelastic behavior of L-PRF. Even
though the elastic modulus is low (0.47 MPa), the membrane is tough (energy to break, 5 N.mm)
and is capable of undergoing significant deformation (217%). Data from suture retention testing,
an indicator of the ability of the membrane to be sutured to the tissues, suggested a significantly
tough and deformable material (modulus-0.2 MPa, strain-140% and energy to break-3.2 N.mm)
in L-PRF. One of the limitations of fibrin products in regenerative medicine is its short biological
life. Made from endogenous fibrin, L-PRF is susceptible to enzyme degradation and undergoes
fibrinolysis. In order to evaluate the resistance of L-PRF to enzyme-mediated degradation, fresh
L-PRF was subjected to trypsin treatment (0.01%) and incubated at 37oC. We observed complete
degradation of L-PRF within three days. Genipin crosslinking of L-PRF membranes decreased
degradation by almost 60%. The ability of L-PRF membranes to support cell growth was
evaluated by culturing mouse calvarial osteoblasts on crosslinked and uncrosslinked membranes.
Uncrosslinked scaffolds underwent degradation to various levels while the genipin crosslinked
membranes retained their structure and supported cell growth.

Conclusion: Based on these findings, it is clear that L-PRF is a novel biomaterial with unique
attributes: predictable preparation from autologous blood, simplicity of protocol, defined
architecture, impressive mechanical properties and abundance of growth factors from activated
platelets. The blood is allowed to clot under physiological conditions with no exposure to anticoagulants, exogenous thrombin and calcium chloride. All of these characteristics make L-PRF
promising biomaterial for applications in regenerative medicine.

INTRODUCTION

The use of blood and blood-derived products to seal wounds and improve healing in different
clinical situations started with fibrin glues, which are mainly fibrinogen concentrates. Addition
of platelets to fibrin glue not only improved their strength but also promoted neoangiogenesis
and regeneration. These benefits are attributed to the release of a variety of peptide growth
factors from the alpha-granules of platelets upon activation1. Platelet concentrates (PC) were
seen as a practical way to deliver growth factors2 and was strongly driven by commercial
interests rather than research characterization3. In fact, PCs are difficult to characterize because
unlike homogenous and defined pharmacological preparations, they are a potpourri of signaling
molecules and blood cells (platelet and leukocytes) entrapped within a fibrin matrix. Different
commercial and proprietary preparations yield a variety of PC that are different in cellular
composition, growth factor recovery and kinetics of release4.

It is important to realize that in most oral surgeries, platelet-rich plasma (PRP) preparations are
used as a gel in open surgical wounds and not as platelet suspensions. In these situations, the
gelation is induced by the addition of thrombin, calcium chloride, batroxobin or other agents and
directly placed in the site of injury5. Due to rapid activation, fibrinogen polymerization is often
incomplete and results in friable fibrin gels with very little mechanical strength. In addition,
injectable PRP gels undergo rapid fibrinolysis6,7.
1

In contrast, the processes of blood coagulation (fibrinogen polymerization), platelet enrichment
and activation occur simultaneously in the preparation of L-PRF. The coagulation cascade is
triggered when whole blood contacts the walls of a dry glass tube and continues throughout the
centrifugation process. This results in the formation of a mechanically-strong blood clot (L-PRF)
that can be surgically handled and used.

Even though L-PRF has been shown to have dense fibrin structure and delayed growth factor
release profile8, detailed mechanical characterization of these membranes are lacking. This is
significant gap in knowledge, given the popularity of these membranes in clinical practice as
well as its potential to be used as a biomaterial. Current study focusses on the protocol for
deriving L-PRF as well as methods that can be employed to study its mechanical properties. This
data is intended to serve as baseline for ongoing studies investigating the viscoelastic properties
of this interesting natural biomaterial.
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MATERIALS AND METHODS

Protocol:
All blood-drawing procedures should be done by licensed and certified professionals. Only one
human subject was used for all experiments, therefore, IRB approval was not required. Special
precautions regarding informed consent and protecting participant identification need to be
followed. All experiments listed in this protocol involve handling of human blood and/or blood
products and appropriate personal protective equipment need to be worn at all times. The waste
should be considered as biohazard and disposed of according to regulations.

Preparation of L-PRF:
10ml of fresh blood samples were collected in glass tubes without anticoagulants from healthy
volunteers (A). The samples were immediately centrifuged at 400g for 15 minutes using a table
top centrifuge Hettich EBA 20 Supplied by Intra-Lock. The L-PRF clots were collected between
the red corpuscles at the bottom and acellular plasma at the top of the tube (B). Thereafter they
were gently compressed to form membranes (C).

3

Uniaxial tensile testing:
The mechanical properties of the L-PRF were characterized by uniaxial tensile testing. L-PRF
membranes (n=6) were punched into “dog bones” (2.75mm wide at their narrowest point with a
gauge length of 7.5mm), thickness of each sample was measured and tested on MTS Bionix 200
testing system with a 50N load cell (MTS systems corp.). The samples were stretched at a rate of
10.0mm/min. Elastic modulus, energy to break, and strain at break were calculated and recorded
by MTS test works 4.0.

Suture retention strength:
L-PRF membranes (n=3) were cut into rectangular samples measuring (10x25mm), thickness of
each sample was measured prior to testing. A pinhole was made in the center of the sample
using a stainless steel orthodontic ligature wire of 220μm thick. The ligature wire was passed
through the pinhole forming a loop and was then fixed to the tensile testing machine (MTS
systems Corp.). The opposite edge of the sample was fixed to the bottom jaw of the testing
machine10. The ligature wire was pulled at a rate of 10.0mm/min. Energy to break, Elastic
modulus and strain at break were calculated and recorded by MTS test works 4.0.

4

Morphological examination:
The surface morphology of L-PRF was studied by scanning electron microscopy (SEM). They
were punched into discs using a 10mm biopsy punch (Acu-punch) and placed in 24 well plate for
further processing. Samples were washed with PBS and fixed with 2.5% glutaraldehyde (in PBS)
for 20 minutes and dehydrated in ethanol solutions of 50%, 70%, 80%, 90% and 100% for 5
minutes each. Followed by drying with 100% hexamethyldisilazane (HMDS) (Sigma Aldrich)
for 3 minutes; excess HMDS was removed and samples aerated overnight 11. They were mounted
on stubs and sputter coated with platinum. Morphology was examined with JEOL LV 5610 SEM
operating at an acceleration voltage of 20KV.

Cross-linking percentage with ninhydrin:
The cross-linking percentage of L-PRF and genipin cross-linked L-PRF were determined using
the ninhydrin assay. To prepare genipin cross-linked L-PRF, membranes were soaked in 4ml of
1% genipin solution in 6 well culture plate for 48 hours and subsequently washed with PBS 12,13.
Both samples were punched into discs using a 10mm biopsy punch and heated with 1ml of 2 %
(w/v) ninhydrin for 15 minutes at 100oC, the solution was cooled to room temperature and
diluted with 1.5ml of 50% ethanol. Thereafter, 200μl aliquots were pipetted into a 96-well plate
and the absorbance was analyzed in a Bio-Tek Synergy 2 micro plate reader at 570nm. A
Glycine standard (1mM-0.031mM) curve was also generated to establish the relationship
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between free amino acid concentration (FAA) and absorbance. Cross-linking percentage was
determined using the formula below12.

𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑓𝑟𝑒𝑒 𝑁𝐻2 𝐺𝑟𝑜𝑢𝑝𝑠 = (

𝐹𝐴𝐴 𝐶𝑜𝑛𝑐 × 𝑁𝐻2 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡
)
𝑠𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡

𝐷𝑒𝑔𝑟𝑒𝑒 𝑜𝑓 𝐶𝑟𝑜𝑠𝑠𝑙𝑖𝑛𝑘𝑖𝑛𝑔
(𝑓𝑟𝑒𝑒 𝑁𝐻2 𝐺𝑟𝑜𝑢𝑝𝑠)𝑃𝑅𝐹 − (𝑓𝑟𝑒𝑒 𝑁𝐻2 𝐺𝑟𝑜𝑢𝑝𝑠)𝐺 − 𝑃𝑅𝐹
=(
× 100)
(𝑓𝑟𝑒𝑒 𝑁𝐻2 𝐺𝑟𝑜𝑢𝑝𝑠)𝑃𝑅𝐹
Biodegradation with trypsin:
L-PRF and genipin cross-linked L-PRF (n=3) were placed in 500μl of 0.01% trypsin and
incubated at 37oC for 3 days, the trypsin solution was refreshed every 24 hours to ensure enzyme
activity. Samples were weighed at day 1 prior to enzyme application and at day 3. The difference
in start and end weight represents enzymatic degradation.14

MTS cell proliferation assay:
To study cell proliferation on crosslinked and uncrosslinked clots, viable cells were determined
by using the colorimetric MTS assay. The principle being that, metabolically active cells will
react with tetrazolium salt in the MTS reagent to produce a soluble formazan dye that can be
spectrophotometrically read at 490nm. MC3T3s (mouse calvarial preosteoblasts) were
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trypsinized and the number of cells were counted with a hemocytometer. 4x105 cells in a
suspension of 300μl were seeded into 10mm cloning rings placed on the top surface of clots in
24 well plate. Cloning ring were removed after 24hours of cell culture. On Day 4 MTS assay was
carried out. The culture medium (αMEM) was changes at a frequency of 3 days. The cellular
constructs were rinsed with PBS thrice for a duration of 5 minutes followed by incubation with
20% MTS reagent in serum free media for 2h. Thereafter, 200μL aliquots were pipetted into a
96-well plate and the samples were analyzed in a Bio Tek Synergy 2 micro plate reader at
490nm.
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RESULTS

The mechanical properties were evaluated in two modes: uniaxial tensile testing and suture
retention strength test. The results demonstrate viscoelastic behavior of L-PRF. Even though
the elastic modulus is low (0.47 MPa), the membrane is tough (energy to break, 5 N.mm) and
is capable of undergoing significant deformation (217%, Figure 5). Data from suture
retention testing, an indicator of the ability of the membrane to be sutured to the tissues,
suggested a significantly tough and deformable material (modulus-0.2 MPa, strain-140% and
energy to break-3.2 N.mm) in L-PRF.

The Scanning Electron Microscope image of the L-PRF clot at different sections (top, middle
and bottom) layer is illustrated in Figure 6. As can be seen, the top left portion is composed
predominantly of fibrin network with no cells. The top right is enriched with platelets with
various degree of activation and degranulation. The lower left shows a buffy coat with
numerous leukocytes. The lower right has a mixture of leukocytes and red blood cells
entrapped within a fibrin matrix.

Degradation of L-PRF membranes following incubation in 0.01% trypsin. All L-PRF
membranes disintegrated completely in trypsin within 3 days while genipin crosslinked L8

PRF were 60% more stable. This shows that chemical crosslinking can be a viable strategy to
improve the longevity of L-PRF membranes when placed in vivo (Table 1).

The ability of L-PRF membranes to support cell growth was evaluated by culturing mouse
calvarial osteoblasts on crosslinked and uncrosslinked membranes. Uncrosslinked scaffolds
underwent degradation to various levels while the genipin crosslinked membranes retained
their structure and supported cell growth (Table 2).
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DISCUSSION

Autologous platelet concentrates are promising in the field of regenerative medicine15 because of
the abundance of growth factors. However, these preparations often lacked a defined structure
that makes surgical manipulation very difficult. Many times, the suspensions and gels are not
retained effectively at the site of delivery, resulting in unpredictable outcomes. L-PRF represents
a huge advance in the evolution of platelet concentrates in that it is essentially a firm fibrin
membrane with entrapped platelets. These solid membranes possess excellent handling
characteristics, and can be securely sutured at an anatomically desired location during open
surgeries. However, its physical and biological properties are relatively unknown.

The L-PRF will form consistently when steps described above are strictly adhered to (Figure 1).
One of the important considerations in generating a good L-PRF membrane is the time delay
between blood draw and centrifugation. The success of L-PRF technique entirely depends on the
speed of blood collection and immediate transfer to the centrifuge16, usually within a minute. It is
impossible to generate a well-structured L-PRF clot (with its specific cell content, matrix
architecture and growth factor release profile), if blood harvesting is prolonged and not
homogenous; a small incoherent, friable mass of fibrin with unknown content is formed instead.
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It has been accepted that mechanobiological interactions between cells and extracellular matrix
(ECM) have a critical influence in all aspects of cell behavior including migration, proliferation
and differentiation17,18. L-PRF, a unique type of blood clot, is formed under specific
circumstances and is comprised of complex, branched network of fibrin. L-PRF functions as a
provisional ECM that is turned over into functional tissue during healing. Being subjected to
mechanical forces, successful healing outcomes are dependent on the structural integrity of LPRF and hence elucidating their physical properties is important. We performed uniaxial tensile
testing (to identify the intrinsic material properties) and suture retention testing (to identify the
failure characteristics) on fresh L-PRF. Unlike PRP gel or clotted blood that does not have a
defined structures, L-PRF resembles dense connective tissue with superior handling
characteristics. We report an elastic modulus of 0.470 MPa (SD=0.107) for L-PRF membranes
and stretch twice its initial length before failure (strain of 215%). These data match with
published literature19,20 who reported low stiffness (1-10 MPa) and high strain (up to 150%)
before breaking. The difference in the values can be due to the use of fibrin network compared to
the use of AFM analysis of single fibrin fiber in the above mentioned studies.

Suture retention strength is a surgically important parameter of graft materials and it is defined as
the force necessary to pull a suture from the graft or cause the wall of the graft to fail. Our
experiments used straight-across procedure (as defined by ANSI21). The force required to the
pull the ligature wire through the L-PRF of 3.23 N.mm (SD=0.329). Overall, we found the L-
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PRF to be mechanically tough, capable of supporting loads and the ability to stretch twice as
much on tension and retains sutures quite well (deforms significantly before tearing).

The lack of stability and structural integrity of L-PRF in biological environments is a major
limitation in its use in tissue engineering. We sought to address this issue by chemically
crosslinking L-PRF using genipin. Unlike gluteraldehyde which is associated with toxicity,
genipin is a naturally occurring biodegradable molecule with low cytotoxicity. After genipin
treatment, the membranes were significantly stable in trypsin and supported cell proliferation
over 4 days. However, only 20% of L-PRF was crosslinked with genipin (determined by
ninhydrin assay). This data suggests that while chemical crosslinking is a viable strategy, other
alternatives need to be explored.

Based on these findings, it is clear that L-PRF is a novel biomaterial with unique attributes:
predictable preparation from autologous blood, simplicity of protocol, defined architecture,
impressive mechanical properties and abundance of growth factors from activated platelets. The
blood is allowed to clot under physiological conditions with no exposure to anti-coagulants,
exogenous thrombin and calcium chloride. All of these characteristics make L-PRF promising
biomaterial for applications in regenerative medicine.

One of the clinical issues to deal with in the application of L-PRF is the heterogeneity in the
quality of platelets and blood components. At present, very little is understood about L-PRF
12

generated from patients with coagulation disorders or patients on medications that affect blood
clotting (heparin, warfarin or platelet inhibitors). Answers to these questions will undoubtedly
improve our understanding of healing as well as contribute to advance the field of personalized
medicine.
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Figure 1: Stages of PRF preparation

Immediately centrifuged at 2700rpm for 12 minutes (A). PRF clots separated from RBC and PPP
(B). Gently compressed to form membranes (C)
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Figure 2: Uniaxial tensile testing on PRF membrane.

An illustration of the initial rest condition wherein PRF membrane cut into a dog bone is
securely held between the grips of tensile testing system.
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Figure 3: Photographs of suture retention strength testing.

1. denotes the initial rest condition 2, 3 & 4 depicts the elongation of the membrane due to the
applied tension and PRF’s resistance to tear.
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Figure 4: SEM Image of different layers of PRF

1 represents the fibrin-rich layer; 2 a zone of enriched platelets with various degree of activation;
3 buffy coat with numerous leukocytes and 4 the red blood cell base.
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Figure 5: Stress-strain curves following mechanical loading of PRF in uniaxial tensile testing
mode (A) and Suture retention strength (B). The loading pattern of each sample is represented in
different color.
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The scanning electron microscope image of the PRF clot at different sections are illustrated
(Figure 6).
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Table 1: Degradation of PRF membranes following incubation in 0.01% trypsin. All PRF
membranes disintegrated completely in trypsin within 3 days while genipin crosslinked PRF
were 60% more stable. This shows that chemical crosslinking can be a viable strategy to
improve the longevity of PRF membranes when placed in vivo.
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Table 2: Effect of PRF crosslinking on cell viability. Representative images of 4 day culture
of MC3T3 cells on uncrosslinked L-PRF (A), genipin-crosslinked L-PRF (B) and tissue
culture plastic (C). Uncrosslinked L-PRF degraded in culture to variable extent and showed
cell activity similar to plastic. Genipin crosslinked L-PRF maintained their structure and
supported robust cell survival. To the left is quantified data from independent experiments
with three replicates.
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